Weakened humoral immune responses of inactivated SARS-CoV-2 vaccines in patients with solid tumors

Cancer Commun (Lond). 2023 Feb;43(2):280-284. doi: 10.1002/cac2.12368. Epub 2022 Nov 4.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • COVID-19 Vaccines / therapeutic use
  • COVID-19* / prevention & control
  • Humans
  • Immunity, Humoral
  • Neoplasms*
  • SARS-CoV-2

Substances

  • COVID-19 Vaccines